Granules India Q2FY27 Revenue Up 20% YoY to ₹15,600 Mn

Granules India announced its Q2FY27 financial results, with revenue from operations reaching INR 15,600 Mn, a 20% year-on-year increase. EBITDA grew by 21% YoY to INR 3,376 Mn, while Profit Before Tax (PBT) rose by 38% YoY to INR 2,434 Mn, and Profit After Tax (PAT) surged by 39% YoY to INR 1,818 Mn. The company noted a shift in revenue share from North America (72% in Q2FY27 vs. 76% in Q2FY26) to Europe (16% in Q2FY27 vs. 12% in Q2FY26). Finished dosages contributed 73% to revenue. Granules India ended the quarter with a net cash position of ₹8,280 million, a significant improvement from a net debt of ₹1,012 million in Q1 FY27. The company also mentioned a constructive US FDA audit at its Gagillapur site and progress in filing potential first-to-file ANDAs.